Paris - Delayed Quote EUR
TME Pharma N.V. (ALTME.PA)
0.0719
-0.0006
(-0.83%)
As of 2:07:05 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.75 | -0.87 |
| Low Estimate | 0 | 0 | -0.75 | -0.87 |
| High Estimate | 0 | 0 | -0.75 | -0.87 |
| Year Ago EPS | -- | -- | -0.16 | -0.75 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 30k | 30k |
| Low Estimate | -- | -- | 30k | 30k |
| High Estimate | -- | -- | 30k | 30k |
| Year Ago Sales | -- | -- | 19k | 30k |
| Sales Growth (year/est) | -- | -- | 57.89% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.75 | -0.87 |
| 7 Days Ago | 0 | 0 | -0.75 | -0.87 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALTME.PA | -- | -- | -368.75% | -16.00% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Related Tickers
IDIAz.XC
VSC.F 4SC AG
3.2100
-13.24%
HPHA.DE Heidelberg Pharma AG
3.2300
0.00%
VVY.AS Vivoryon Therapeutics N.V.
1.7600
+2.09%
ALGAE.PA FERMENTALG
0.5920
0.00%
NYKD.OL Nykode Therapeutics AS
2.6800
+0.07%
ALCLS.PA Cellectis S.A.
1.3500
-0.59%
ALNEV.PA Neovacs S.A.
0.0050
-19.35%
VICO.ST Vicore Pharma Holding AB (publ)
7.89
-7.61%
ATORX.ST Alligator Bioscience AB (publ)
4.2300
+5.94%